Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Calithera Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Calithera Biosciences Raises USD14.5 Million in Venture Financing 10
Calithera Biosciences Raises USD16 Million in Venture Financing 11
Calithera Biosciences Raises US$35 Million In Series D Financing 12
Calithera Biosciences Raises US$2 Million In Series C Financing 14
Calithera Biosciences Raises Additional US$4 Million In Series B Financing 15
Partnerships 17
Calithera Biosciences Enters into Partnership with Pfizer 17
Bristol-Myers Squibb and Calithera Biosciences Expand Agreement 18
ProTrials Research Enters into Agreement with Calithera Biosciences 19
Licensing Agreements 20
Incyte Enters into Licensing Agreement with Calithera Biosciences 20
Calithera Biosciences Enters into Licensing Agreement with Mars Symbioscience 22
Equity Offering 23
Calithera Biosciences to Raise up to USD50 Million in Public Offering of Shares 23
Calithera Biosciences Raises USD38 Million in Public Offering of Shares 24
Calithera Biosciences Raises USD80.5 Million in Public Offering of Shares 25
Calithera Biosciences Raises USD8 Million in Private Placement of Shares 27
Calithera Biosciences Raises USD80 Million in IPO 29
Calithera Biosciences Inc – Key Competitors 31
Calithera Biosciences Inc – Key Employees 32
Calithera Biosciences Inc – Locations And Subsidiaries 33
Head Office 33
Recent Developments 34
Financial Announcements 34
Aug 07, 2018: Calithera Biosciences reports second quarter 2018 financial results and recent highlights 34
May 10, 2018: Calithera Biosciences Reports First Quarter 2018 Financial Results and Recent Highlights 36
Mar 08, 2018: Calithera Biosciences Reports Fourth Quarter 2017 Financial Results and Recent Highlights 38
Nov 02, 2017: Calithera Biosciences Reports Third Quarter 2017 Financial Results and Recent Highlights 40
Aug 08, 2017: Calithera Biosciences Reports Second Quarter 2017 Financial Results and Recent Highlights 41
May 09, 2017: Calithera Biosciences Reports First Quarter 2017 Financial Results and Recent Highlights 42
Mar 16, 2017: Calithera Biosciences Reports Fourth Quarter and Full Year 2016 Financial Results and Recent Highlights 44
Corporate Communications 46
Oct 03, 2017: Calithera Biosciences Announces Appointment of Sumita Ray as General Counsel 46
Sep 21, 2017: Calithera Biosciences Appoints Blake Wise to Board of Directors 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Calithera Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Calithera Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Calithera Biosciences Raises USD14.5 Million in Venture Financing 10
Calithera Biosciences Raises USD16 Million in Venture Financing 11
Calithera Biosciences Raises US$35 Million In Series D Financing 12
Calithera Biosciences Raises US$2 Million In Series C Financing 14
Calithera Biosciences Raises Additional US$4 Million In Series B Financing 15
Calithera Biosciences Enters into Partnership with Pfizer 17
Bristol-Myers Squibb and Calithera Biosciences Expand Agreement 18
ProTrials Research Enters into Agreement with Calithera Biosciences 19
Incyte Enters into Licensing Agreement with Calithera Biosciences 20
Calithera Biosciences Enters into Licensing Agreement with Mars Symbioscience 22
Calithera Biosciences to Raise up to USD50 Million in Public Offering of Shares 23
Calithera Biosciences Raises USD38 Million in Public Offering of Shares 24
Calithera Biosciences Raises USD80.5 Million in Public Offering of Shares 25
Calithera Biosciences Raises USD8 Million in Private Placement of Shares 27
Calithera Biosciences Raises USD80 Million in IPO 29
Calithera Biosciences Inc, Key Competitors 31
Calithera Biosciences Inc, Key Employees 32
List of Figures
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8